An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Purpose of Study: To examine 1) the short and long-term effectiveness and tolerability of
quetiapine (extended release) XR for the treatment of social anxiety disorder (SAD); and 2)
continuation effects of quetiapine XR in preventing SAD relapse.